| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/13/1997 | US5629292 Use of angiotensin III and analogs thereof in tissue repair |
| 05/13/1997 | US5629204 Peptide related to human programmed cell death and DNA encoding it |
| 05/13/1997 | US5629193 Paraoxonase |
| 05/13/1997 | US5629026 Gastric disorders |
| 05/09/1997 | WO1997016729A1 Combinatorial dihydrobenzopyran library |
| 05/09/1997 | WO1997016451A1 Fused tropane-derivatives as neurotransmitter reuptake inhibitors |
| 05/09/1997 | WO1997016443A1 Farnesyl transferase inhibiting 2-quinolone derivatives |
| 05/09/1997 | WO1997016442A1 Substituted pyridyl pyrroles, compositions containing such compounds and methods of use |
| 05/09/1997 | WO1997016440A1 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives |
| 05/09/1997 | WO1997016438A1 Triterpene derivatives with immunosuppressant activity |
| 05/09/1997 | WO1997016435A1 3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitors |
| 05/09/1997 | WO1997016434A1 (-) cis-6(s)-phenyl-5(r)[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol d-tartrate |
| 05/09/1997 | WO1997016433A1 Protease inhibitors |
| 05/09/1997 | WO1997016430A1 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
| 05/09/1997 | WO1997016183A1 Thiamorphinans with neuroprotective activity |
| 05/09/1997 | WO1997016177A1 Method of inhibiting cathepsin k |
| 05/09/1997 | WO1996034885A3 Biologically active peptide fragments of ob protein |
| 05/09/1997 | CA2236171A1 Triterpene derivatives with immunosuppressant activity |
| 05/09/1997 | CA2234641A1 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
| 05/09/1997 | CA2232355A1 Thiamorphinans with neuroprotective activity |
| 05/09/1997 | CA2209109A1 Method of inhibiting cathepsin k |
| 05/07/1997 | EP0771877A1 Gene coding for modified bone morphogenic protein receptor |
| 05/07/1997 | EP0771818A2 Biotin derivatives |
| 05/07/1997 | EP0771815A1 Sulfated and phosphated saccharide derivatives, process for the preparation of the same and use thereof |
| 05/07/1997 | EP0771813A1 Alkylxanthine phosphonates and alkylxanthine phosphine oxydes and their use as medicines |
| 05/07/1997 | EP0771800A2 Dioxino derivatives and their use as dopamine agonists |
| 05/07/1997 | EP0771799A1 Purin-6-one derivatives |
| 05/07/1997 | EP0771795A1 New glycomimetics as Selectin antagonists, and anti-imflammation pharmaceutical compositions |
| 05/07/1997 | EP0771791A1 Ethylamino carbazole melatonergic agents |
| 05/07/1997 | EP0771788A2 Substituted sulphonimidamides, method for their preparation, their use as medicament or diagnostic and medicament containing them |
| 05/07/1997 | EP0771324A1 Concentrate of fibrinogene obtained from blood plasma, process and plant for its preparation |
| 05/07/1997 | EP0771215A1 Retroviral transduction of cells using soluble complement inhibitors |
| 05/07/1997 | EP0771210A1 TWO NON-CONTIGUOUS REGIONS CONTRIBUTE TO NIDOGEN BINDING TO A SINGLE EGF-LIKE MOTIF OF THE LAMININ $g(g)1 CHAIN |
| 05/07/1997 | EP0771209A2 Novel peptides |
| 05/07/1997 | EP0771206A1 Hard tissue stimulating agent |
| 05/07/1997 | EP0771204A1 Methods for treating sepsis or inflammatory diseases with oxypurine nucleosides |
| 05/07/1997 | EP0771196A1 Excitatory amino acid receptor antagonists |
| 05/07/1997 | EP0771193A1 Activation of growth factors by matrix vesicles |
| 05/07/1997 | EP0667780A4 Purified ceramide-activated protein kinase, assay for identifying agents which act on same, and methods of using said agents. |
| 05/07/1997 | EP0626956B1 Quinolylbenzofuran derivatives as leukotriene antagonists |
| 05/07/1997 | EP0464155B1 Endothelial cell growth factor, isolation and expression |
| 05/07/1997 | DE19541283A1 Neue Aminosäurederivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen New amino acid derivatives, to processes for their preparation containing these compounds and pharmaceutical compositions |
| 05/07/1997 | CN1149294A A process for preparing 1-butyl-2-[2'-(2H-tetrazol-5-YL)-biphenyl-4-ylmethyl]-1H-indole-3-carboxylic acid |
| 05/07/1997 | CN1149293A Process for preparing 1-butyl-2-[2'-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-1H-indole-3-carboxylic acid |
| 05/07/1997 | CN1149292A Pyrimidinyl derivatives as interleukin inhibitors |
| 05/07/1997 | CN1149288A Vitamin-D amide derivatives |
| 05/07/1997 | CN1149252A Novel substituted tryptamines, phenalkylamines and related compounds |
| 05/07/1997 | CN1149051A Pyrimidinedione, pyrimidinetrione, triazinedione, tetrahydroquinazolinedione derivatives as alpha1 adrenergic receptor antagonists |
| 05/07/1997 | CN1149046A New substituted 2,2-dimethyl-omega-phenoxyalkanoic acids and esters, process for their preparation and pharmaceutical compositions containing them |
| 05/07/1997 | CA2189501A1 Nk-1 receptor antagonists for the treatment of cancer |
| 05/07/1997 | CA2189401A1 Purin-6-one derivatives |
| 05/06/1997 | USH1649 HIV protease inhibitor combinations |
| 05/06/1997 | US5627286 Metal complexes, diagnostic and theraputic agents |
| 05/06/1997 | US5627278 Process for preparing compounds containing a fused bicyclic ring |
| 05/06/1997 | US5627207 Cancer |
| 05/06/1997 | US5627203 Tricyclic oxime ethers |
| 05/06/1997 | US5627198 Blood metal concentrations |
| 05/06/1997 | US5627186 Treatment of htlv or aids with 4-amino-1-(2-hydroxymethyl oxathiolan-5-yl)-1h-pyrimidin-2-one with 3'-azido-3'-deoxy thymidine |
| 05/06/1997 | US5627182 δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides |
| 05/06/1997 | US5627177 Anxiolytic |
| 05/06/1997 | US5627173 Phosphonoacetic acid derivatives and their use for treating degenerative joint disorders |
| 05/06/1997 | US5627168 Inhibition of the unidirectional efflux of the excitatory amino acid antagonist from the brain; antiepileptic and anxiolytic agents; schizophrenia, analgesics; neurodegenerative diseases |
| 05/06/1997 | US5627154 Calcium channel blocking polypeptides from Heteropoda venatoria |
| 05/06/1997 | US5627050 Bone-related sulfatase-like protein and process for its production |
| 05/06/1997 | US5626860 Treatment of diabetes and reduction of fat stores |
| 05/06/1997 | CA2001359C Methods for the treatment and prophylaxis of pneumocystis carinii pneumonia and other diseases and compounds and formulations for use in said methods |
| 05/03/1997 | CA2189222A1 Alkylxanthine phosphonates and alkylxanthine phosphine oxides and their use as pharmaceuticals |
| 05/02/1997 | EP0770624A2 Peptide capable of inducing immune response to human gastric cancer and agent containing it for preventing or treating human gastric cancer |
| 05/02/1997 | EP0770622A2 Cyclic adhesion inhibitors |
| 05/02/1997 | EP0770606A1 Cis-epoxide derivate useful as irreversible HIV protease inhibitor and process for its preparation |
| 05/02/1997 | EP0770395A1 Use of botulinum toxins for treating headache |
| 05/02/1997 | EP0770393A2 Prolongation of organ transplantation using rapamycin loaded donor splenocytes |
| 05/02/1997 | EP0770392A2 Use of salts of lanthanide, tin, zinc, manganese, yttrium, cobalt, strontium in a pharmaceutical composition |
| 05/02/1997 | EP0770391A2 Use of salts of lanthanide, tin, zinc, manganese, yttrium, cobalt, strontium in pharmaceutical compositions |
| 05/02/1997 | EP0770390A1 Nasally administrable compositions containing physiologically active peptides |
| 05/02/1997 | EP0770385A1 Use of astaxanthin for the treatment of stress |
| 05/02/1997 | EP0770137A1 Improvements in production of proteins in host cells |
| 05/02/1997 | EP0770089A1 Growth differentiation factor-12 |
| 05/02/1997 | EP0770081A1 Heterocycle-condensed morphinoid derivatives |
| 05/02/1997 | EP0770079A1 Heterobicyclic derivatives |
| 05/02/1997 | EP0770077A1 Process for the preparation of 2-(1-azabicyclo(2.2.2)oct-3-yl) -2,4,5,6-tetrahydro-1h-benz(de)isoquinolin-1-one and intermediate product |
| 05/02/1997 | EP0770076A1 Benzocondensed five membered heterocycle carboxamides as 5ht2b/2c receptor antagonists |
| 05/02/1997 | EP0770068A1 Conformationally rigid bicyclic and adamantane derivatives useful as alpha 2-adrenergic blocking agents |
| 05/02/1997 | EP0770065A1 Tri-substituted phenyl derivates useful as pde iv inhibitors |
| 05/02/1997 | EP0770059A1 Substituted benzamidines, their production and their use as medicaments |
| 05/02/1997 | EP0770058A1 Novel chemical compound, its preparation and use as a drug |
| 05/02/1997 | EP0769961A1 Attenuation of wound healing processes |
| 05/02/1997 | EP0769960A1 Pharmaceutical compositions containing a bile salt and a buffer for increased bioavailability of an active compound |
| 05/02/1997 | EP0769958A1 Inhibitors of leukocyte adhesion |
| 05/02/1997 | EP0769950A1 Method and compound for the treatment of hair loss |
| 05/02/1997 | EP0769947A1 Indolinone compounds for the treatment of disease |
| 05/02/1997 | EP0769946A1 Methods of maintaining teeth and oral bone |
| 05/02/1997 | EP0769945A1 Methods for bone healing and fracture repair |
| 05/02/1997 | EP0769944A1 Methods for inhibiting bone prosthesis degeneration |
| 05/02/1997 | EP0769942A1 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug |
| 05/02/1997 | EP0769940A1 INDENE sPLA 2? INHIBITORS |
| 05/02/1997 | EP0769939A1 Use of inhibitors of human s-cd23 |
| 05/02/1997 | EP0648202B1 Substituted (arylalkylaminobenzyl)aminopropionamide derivatives, their preparation and use anti-epileptic, neuroprotective and antidepressant agents |
| 05/02/1997 | EP0328552B2 Thrombin derived polypeptides, compositions and methods for use |
| 05/01/1997 | WO1997015594A1 Novel chemokine for mobilizing stem cells |